Questionable Immunity to Mumps among Healthcare Workers in Italy—A Cross-Sectional Serological Study
Abstract
:1. Introduction
2. Materials and Methods
3. Results
3.1. Study Population
3.2. Serological Evaluation
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Fortunato, F.; Tafuri, S.; Cozza, V.; Martinelli, D.; Prato, R. Low vaccination coverage among Italian healthcare workers in 2013. Hum. Vaccines Immunother. 2015, 11, 133–139. [Google Scholar] [CrossRef] [PubMed]
- Coppeta, L.; Balbi, O.; Baldi, S.; Pietroiusti, A.; Magrini, A. Pre-vaccination IgG screening for mumps is the most cost-effectiveness immunization strategy among Health Care Workers. Hum. Vaccines Immunother. 2019, 15, 1135–1138. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Ferrari, C.; Trabucco Aurilio, M.; Mazza, A.; Pietroiusti, A.; Magrini, A.; Balbi, O.; Bolcato, M.; Coppeta, L. Evaluation of Im-munity for Mumps among Vaccinated Medical Students. Vaccines 2021, 9, 599. [Google Scholar] [CrossRef] [PubMed]
- Lee, J.E.; Lee, S.O.; Kang, J.S.; Yi, J.; Kim, K.-H. Investigation of a Mumps Outbreak in a Dental Clinic at a University Hospital. Infect. Chemother. 2019, 51, 256–262. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Marin, M.; Marlow, M.; Moore, K.L.; Patel, M. Recommendation of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Vi-rus-Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak. MMWR Morb. Mortal. Wkly. Rep. 2018, 67, 33–38. [Google Scholar] [CrossRef] [PubMed]
- Kontio, M.; Jokinen, S.; Paunio, M.; Peltola, H.; Davidkin, I. Waning antibody levels and avidity: Implications for MMR vac-cine-induced protection. J. Infect. Dis. 2012, 206, 1542–1548. [Google Scholar] [CrossRef]
- Eriksen, J.; Davidkin, I.; Kafatos, G.; Andrews, N.; Barbara, C.; Cohen, D.; Duks, A.; Griskevicius, A.; Johansen, K.; Bartha, K.; et al. Seroepidemiology of mumps in Europe (1996–2008): Why do outbreaks occur in highly vaccinated populations? Epidemimology Infect. 2013, 141, 651–666. [Google Scholar] [CrossRef] [PubMed]
- Ministry of Health. National Vaccine Prevention Plan 2023–2025, Italy; Ministry of Health: Rome, Italy, 2023.
- CDC. Recommendations of the Immunization Practices Advisory Committee Mumps Prevention. 9 June 1989. Available online: https://www.cdc.gov/mmwr/preview/mmwrhtml/00001404.htm (accessed on 3 November 2023).
- Italian Society of Occupational Medicine (SIML). The Main Vaccinations for Healthcare Professionals: Operational guidelines by the SIML Permanent Commission “Health Doctors”; Italian Society of Occupational Medicine (SIML): Rome, Italy, 2022. [Google Scholar]
- Dilcher, M.; Barratt, K.; Douglas, J.; Strathdee, A.; Anderson, T.; Werno, A. Monitoring viral genetic variation as a tool to im-prove molecular diagnosis for mumps virus. J. Clin. Microbiol. 2018, 56, 10-1128. [Google Scholar] [CrossRef] [PubMed]
- Vygen, S.; Fischer, A.; Meurice, L.; Njoya, I.M.; Gregoris, M.; Ndiaye, B.; Ghenassia, A.; Poujol, I.; Stahl, J.P.; Antona, D.; et al. Waning immunity against mumps in vaccinated young adults, France 2013. Eurosurveillance 2016, 21, 30156. [Google Scholar] [CrossRef]
- Ramanathan, R.; Voigt, E.; Kennedy, R.; Poland, G. Knowledge gaps persist and hinder progress in eliminating mumps. Vaccine 2018, 36, 3721–3726. [Google Scholar] [CrossRef]
- Rubin, S.; Kennedy, R.; Poland, G. Emerging mumps infection. Pediatr. Infect. Dis. J. 2016, 35, 799–801. [Google Scholar] [CrossRef] [PubMed]
- Carr, M.J.; Moss, E.; Waters, A.; Dean, J.; Jin, L.; Coughlan, S.; Connell, J.; Hall, W.W.; Hassan, J. Molecular epidemiological evaluation of the recent resurgence in mumps virus infections in Ireland. J. Clin. Microbiol. 2010, 48, 3288–3294. [Google Scholar] [CrossRef] [PubMed]
- Nelson, G.E.; Aguon, A.; Valencia, E.; Oliva, R.; Guerrero, M.L.; Reyes, R.; Lizama, A.; Diras, D.; Mathew, A.M.; Camacho, E.J.M.; et al. Epidemiology of a mumps outbreak in a highly vaccinated island population and use of a third dose of mea-sles-mumps-rubella vaccine for outbreak control—Guam 2009 to 2010. Pediatr. Infect. Dis. J. 2013, 32, 374–380. [Google Scholar] [CrossRef] [PubMed]
- Lee, C.Y.; Tang, R.B.; Huang, F.Y.; Tang, H.; Huang, L.M.; Bock, H.L. A new measles mumps rubella (MMR) vaccine: A ran-domized comparative trial for assessing the reactogenicity and immunogenicity of three consecutive production lots and comparison with a widely used MMR vaccine in measles primed children. Int. J. Infect. Dis. 2002, 6, 202–209. [Google Scholar] [CrossRef] [PubMed]
- McLean, G.S.; Fiebelkorn, H.Q.; Temte, A.P.; Wallace, J.L. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: Summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recom-Mendation Rep. 2013, 62, 1–34. [Google Scholar]
- Wiedermann, U.; Garner-Spitzer, E.; Wagner, A. Primary vaccine failure to routine vaccines: Why and what to do? Hum. Vaccines Immunother. 2016, 12, 239–243. [Google Scholar] [CrossRef]
- Barskey, A.E.; Glasser, J.W.; LeBaron, C.W. Mumps resurgences in the United States: A historical perspective on unexpected elements. Vaccine 2009, 27, 6186–6195. [Google Scholar] [CrossRef]
- Dayan, G.H.; Quinlisk, M.P.; Parker, A.A.; Barskey, A.E.; Harris, M.L.; Schwartz, J.M.H.; Hunt, K.; Finley, C.G.; Leschinsky, D.P.; O’Keefe, A.L.; et al. Recent resurgence of mumps in the United States. N. Engl. J. Med. 2008, 358, 1580–1589. [Google Scholar] [CrossRef]
- Date, A.A.; Kyaw, M.H.; Rue, A.M.; Julie, K.; Obrecht, L.; Krohn, T.; Rowland, J.; Rubin, S.; Safranek, T.J.; Bellini, W.J.; et al. Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a uni-versity population. J. Infect. Dis. 2008, 197, 1662–1668. [Google Scholar] [CrossRef]
- Lewnard, J.A.; Grad, Y.H. Vaccine waning and mumps re-emergence in the United States. Sci. Transl. Med. 2018, 10, eaao5945. [Google Scholar] [CrossRef]
- Kennedy, R.B.; Ovsyannikova, I.G.; Thomas, A.; Larrabee, B.R.; Rubin, S.; Poland, G.A. Differential durability of immune responses to measles and mumps following MMR vaccination. Vaccine 2019, 37, 1775–1784. [Google Scholar] [CrossRef] [PubMed]
- Hassan, J.; Dean, J.; Moss, E.; Carr, M.J.; Hall, W.W.; Connell, J. Seroepidemiology of the recent mumps virus outbreaks in Ireland. J. Clin. Virol. 2012, 53, 320–324. [Google Scholar] [CrossRef] [PubMed]
- Rubin, S.A.; Qi, L.; Audet, S.A.; Sullivan, B.; Carbone, K.M.; Bellini, W.J.; Rota, P.A.; Sirota, L.; Beeler, J.; Timmann, C.; et al. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. J. Infect. Dis. 2008, 198, 508–515. [Google Scholar] [CrossRef]
- Kenny, L.; O’Kelly, E.; Connell, J.; De Gascun, C.; Hassan, J. Mumps outbreaks in a highly vaccinated population: Investigation of a neutralization titer against the currently circulating wildtype genotype G5 mumps virus. J. Clin. Virol. 2016, 74, 8–12. [Google Scholar] [CrossRef] [PubMed]
- LeBaron, C.W.; Forghani, B.; Beck, C.; Brown, C.; Bi, D.; Cossen, C.; Sullivan, B.J. Persistence of mumps antibodies after 2 doses of measles-mumps-rubella vaccine. J. Infect. Dis. 2009, 199, 552–560. [Google Scholar] [CrossRef]
- Gothefors, L.; Bergstrom, E.; Backman, M. Immunogenicity and reactogenicity of a new measles, mumps and rubella vaccine when administered as a second dose at 12 years of age. Scand. J. Infect. Dis. 2001, 33, 545–549. [Google Scholar]
- Cohen, C.; White, J.M.; Savage, E.J.; Glynn, J.R.; Choi, Y.; Andrews, N.; Brown, D.; Ramsay, M.E. Vaccine efficacy estimates, mumps epidemic 2004-2005, England. Emerg. Infect. Dis. 2007, 13, 12. [Google Scholar] [CrossRef]
- Peltola, H.; Kulkarni, P.S.; Kapre, S.V.; Paunio, M.; Jadhav, S.S.; Dhere, R.M. Mumps outbreaks in Canada and the United States: Time for new thinking on mumps vaccines. Clin. Infect. Dis. 2007, 45, 459–466. [Google Scholar] [CrossRef] [PubMed]
- Shah, M.; Quinlisk, P.; Weigel, A.; Riley, J.; James, L.; Patterson, J.; Hickman, C.; Rota, P.A.; Stewart, R.; Clemmons, N.; et al. Mumps outbreak in a highly vaccinated universi-ty-affiliated setting before and after a measles-mumps-rubella vaccination campaign- Iowa, July 2015–May 2016. Clin. -Fectious Dis. 2018, 66, 81–88. [Google Scholar] [CrossRef]
- Golwalkar, M.; Pope, B.; Stauffer, J.; Snively, A.; Clemmons, N. Mumps outbreaks at four universities-Indiana, 2016. Morb. Mortal. Wkly. Rep. 2018, 67, 793–797. [Google Scholar] [CrossRef]
- Cardemil, C.V.; Dahl, R.M.; James, L.; Wannemuehler, K.; Gary, H.E.; Shah, M.; Marin, M.; Riley, J.; Feikin, D.R.; Patel, M.; et al. Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control. N. Engl. J. Med. 2017, 377, 947–956. [Google Scholar] [CrossRef]
- Dhiman, N.; Ovsyannikova, I.G.; Jacobson, R.M.; Vierkant, R.A.; Pankratz, V.S.; Jacobsen, S.J.; Poland, G.A. Correlates of lymphoproliferative responses to measles, mumps, and rubella (MMR) virus vaccines following MMR-II vaccination in healthy children. Clin. Immunol. 2005, 115, 154–161. [Google Scholar] [CrossRef]
- Hanna-Wakim, R.; Yasukawa, L.L.; Sung, P.; Arvin, A.M.; Gans, H.A. Immune responses to mumps vaccine in adults who were vaccinated in childhood. J. Infect. Dis. 2008, 197, 1669–1675. [Google Scholar] [CrossRef] [PubMed]
- Rubin, S.A.; Link, M.A.; Sauder, C.J.; Zhang, C.; Ngo, L.; Rima, B.K.; Duprex, W.P. Recent mumps outbreaks in vaccinated populations: No evidence of immune escape. J. Virol. 2012, 86, 615–620. [Google Scholar] [CrossRef] [PubMed]
- Zipfel, C.M.; Colizza, V.; Bansal, S. The missing season: The impacts of the COVID-19 pandemic on influenza. Vaccine 2021, 39, 3645–3648. [Google Scholar] [CrossRef] [PubMed]
- Chen, B.; Wang, M.; Huang, X.; Xie, M.; Pan, L.; Liu, H.; Liu, Z.; Zhou, P. hanges in Incidence of Notifiable Infectious Diseases in China Under the Prevention and Control Measures of COVID-19. Front. Public Health 2021, 9, 728768. [Google Scholar] [CrossRef] [PubMed]
- Chow, E.J.; Uyeki, T.M.; Chu, H.Y. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat. Rev. Microbiol. 2022, 21, 195–210. [Google Scholar] [CrossRef]
- Smetana, J.; Chlibek, R.; Hanovcova, I.; Sosovickova, R.; Smetanova, L.; Polcarova, P.; Gal, P.; Dite, P. Serological investigation of mumps antibodies in adults in the Czech Republic and the need for changes to the vaccination strategy. Hum. Vaccines Immunother. 2018, 14, 887–893. [Google Scholar] [CrossRef]
- Braeye, T.; Linina, I.; De Roy, R.; Hutse, V.; Wauters, M.; Cox, P.; Mak, R. Mumps increase in Flanders, Belgium, 2012–2013: Results from temporary mandatory notification and a cohort study among university students. Vaccine 2014, 32, 4393–4398. [Google Scholar] [CrossRef]
- Domínguez, A.; Torner, N.; Castilla, J.; Batalla, J.; Godoy, P.; Guevara, M.; Carnicer, D.; Caylà, J.; Rius, C.; Jansà, J.M. Mumps vaccine effectiveness in highly im-munized populations. Vaccine 2010, 28, 3567–3570. [Google Scholar] [CrossRef]
- Waugh, C.J.; Willocks, L.J.; Templeton, K.; Stevenson, J. Recurrent outbreaks of mumps in Lothian and the impact of waning immunity. Epidemiol. Infect. 2020, 148, e131. [Google Scholar] [CrossRef] [PubMed]
- European Centre for Disease Prevention and Control. Measles on the Rise in the EU/EEA: Considerations for Public Health Response; 16 February 2024; ECDC: Stockholm, Sweden, 2024. [Google Scholar]
- Iro, M.A.; Sadarangani, M.; Goldacre, R.; Nickless, A.; Pollard, A.J.; Goldacre, M.J. 30-year trends in admission rates for en-cephalitis in children in England and effect of improved diagnosis and measles-mumps-rubella vaccination: A population-based observational st. Lancet Infect. Dis. 2017, 17, 422–430. [Google Scholar] [CrossRef] [PubMed]
- Connell, A.R.; Connell, J.; Leahy, T.R.; Hassan, J. Mumps Outbreaks in Vaccinated Populations—Is It Time to Re-assess the Clinical Efficacy of Vaccines? Front. Immunol. 2020, 11, 2089. [Google Scholar] [CrossRef] [PubMed]
- Yung, C.-F.; Andrews, N.; Bukasa, A.; Brown, K.E.; Ramsay, M. Mumps complications and effects of mumps vaccination, England and Wales, 2002–2006. Emerg. Infect. Dis. 2011, 17, 661–667. [Google Scholar] [CrossRef] [PubMed]
- Zamir, C.S.; Schroeder, H.; Shoob, H.; Abramson, N.; Zentner, G. Characteristics of a large mumps outbreak: Clinical severity, complications and association with vaccination status of mumps outbreak cases. Hum. Vaccines Immunother. 2015, 11, 1413–1417. [Google Scholar] [CrossRef] [PubMed]
- Beleni, A.-I.; Borgmann, S. Mumps in the Vaccination Age: Global Epidemiology and the Situation in Germany. Int. J. Environ. Res. Public Health 2018, 15, 1618. [Google Scholar] [CrossRef] [PubMed]
- Rasheed, M.A.U.; Hickman, C.J.; McGrew, M.; Sowers, S.B.; Mercader, S.; Hopkins, A.; Grimes, V.; Yu, T.; Wrammert, J.; Mulligan, M.J.; et al. Decreased humoral immunity to mumps in young adults immunized with MMR vaccine in childhood. Proc. Natl. Acad. Sci. USA 2019, 116, 19071–19076. [Google Scholar] [CrossRef] [PubMed]
- Flanagan, K.L.; Fink, A.L.; Plebanski, M.; Klein, S.L. Sex and Gender Differences in the Outcomes of Vaccination over the Life Course. Annu. Rev. Cell Dev. Biol. 2017, 33, 577–599. [Google Scholar] [CrossRef] [PubMed]
- Klein, S.L.; Jedlicka, A.; Pekosz, A. The Xs and Y of immune responses to viral vaccines. Lancet Infect. Dis. 2010, 10, 338–349. [Google Scholar] [CrossRef] [PubMed]
- Choi, K.M. Reemergence of mumps. Korean J. Pediatr. 2010, 53, 623. [Google Scholar] [CrossRef]
- Ryu, J.-U.; Kim, E.-K.; Youn, Y.-S.; Rhim, J.-W.; Lee, K.-Y. Outbreaks of mumps: An observational study over two decades in a single hospital in Korea. Korean J. Pediatr. 2014, 57, 396–402. [Google Scholar] [CrossRef]
- Italian Parliament. Italian Legislative Decree 73/2017; Italian Parliament: Rome, Italy, 2017.
- ISS Epicentro. Le Vaccinazioni in Italia. Available online: https://www.epicentro.iss.it/vaccini/dati_Ita#parotite (accessed on 3 November 2023).
- Terada, K.; Itoh, Y.; Wakabayashi, T.; Teranishi, H.; Akaike, H.; Ogita, S.; Ouchi, K. Rubella specific cell-mediated and humoral immunity following vaccination in college students with low antibody titers. Vaccine 2015, 33, 6093–6098. [Google Scholar] [CrossRef] [PubMed]
- Dayan, G.H.; Rubin, S. Mumps outbreaks in vaccinated populations: Are available mumps vaccines effective enough to prevent outbreaks? Clin. Infect. Dis. 2008, 47, 1458–1467. [Google Scholar] [CrossRef] [PubMed]
- Amanna, I.J.; Carlson, N.E.; Slifka, M.K. Duration of humoral immunity to common viral and vaccine antigens. N. Engl. J. Med. 2007, 357, 1903–1915. [Google Scholar] [CrossRef] [PubMed]
- Paris, C.; Bénézit, F.; Geslin, M.; Polard, E.; Baldeyrou, M.; Turmel, V.; Tadié, É.; Garlantezec, R.; Tattevin, P. COVID-19 vaccine hesitancy among healthcare workers. Infect. Dis. Now 2021, 51, 484–487. [Google Scholar] [CrossRef] [PubMed]
- Aurilio, M.T.; Mennini, F.S.; Gazzillo, S.; Massini, L.; Bolcato, M.; Feola, A.; Ferrari, C.; Coppeta, L. Intention to Be Vaccinated for COVID-19 among Italian Nurses during the Pandemic. Vaccines 2021, 9, 500. [Google Scholar] [CrossRef]
- Coppeta, L.; Morucci, L.; Pietroiusti, A.; Magrini, A. Cost-effectiveness of workplace vaccination against measles. Hum. Vaccines Immunother. 2019, 15, 2847–2850. [Google Scholar] [CrossRef]
Categories | Number | Percent (%) | |
---|---|---|---|
Gender | Male | 164 | 35 |
Female | 304 | 65 | |
Task | Nurses | 136 | 29.1 |
Physicians | 202 | 43.2 | |
Technicians | 96 | 20.5 | |
Other | 34 | 7.2 | |
Years of service | <10 | 229 | 53.8 |
>10 | 197 | 46.2 | |
Continent | South America | 2 | 0.4 |
Central America | 1 | 0.2 | |
North America | 1 | 0.2 | |
Asia | 8 | 1.7 | |
Europe | 456 | 97.5 | |
Italy | 418 | 89.3 (91.7 of European) | |
Age class | >50 years | 40 | 8.5 |
≤50 years | 428 | 91.5 | |
>23 years | 404 | 86.3 | |
≤23 years | 64 | 13.7 |
Categories | Protected (%) | Mean Titer | p-Value | |||
---|---|---|---|---|---|---|
YES | NO | N (S/CO) | ±sd | |||
Gender | Male | 92.7 | 7.3 | 2.99 | 1.38 | n.s. |
Female | 91.1 | 8.9 | 3.13 | 1.26 | ||
Task | Nurses | 90.4 | 9.6 | 3.05 | 1.27 | n.s. |
Physicians | 93.1 | 6.9 | 3.30 | 1.30 | ||
Technicians | 91.7 | 8.3 | 3.03 | 1.20 | ||
Other | 88.2 | 11.8 | 3.33 | 1.25 | ||
Year of service | <10 | 92.6 | 7.4 | 3.08 | 1.25 | n.s. |
>10 | 90.9 | 9.1 | 3.24 | 1.31 | ||
Continent | South America | 50.0 | 50.0 | 3.19 | 1.43 | n.s. |
Central America | 100 | 0 | 3.59 | 0.28 | ||
North America | 100 | 0 | 3.51 | 1.40 | ||
Asia | 87.5 | 13.5 | 3.09 | 1.41 | ||
Europe | 91.8 | 8.2 | 3.18 | 1.27 | ||
Age class | >50 years | 95.3 | 4.7 | 3.30 | 1.09 | <0.05 |
≤50 years | 90.3 | 9.7 | 3.08 | 1.29 | ||
>23 years | 91.3 | 8.7 | 3.20 | 1.29 | n.s. | |
≤23 years | 93.8 | 6.3 | 2.87 | 1.16 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ferrari, C.; Somma, G.; Treglia, M.; Pallocci, M.; Passalacqua, P.; Di Giampaolo, L.; Coppeta, L. Questionable Immunity to Mumps among Healthcare Workers in Italy—A Cross-Sectional Serological Study. Vaccines 2024, 12, 522. https://doi.org/10.3390/vaccines12050522
Ferrari C, Somma G, Treglia M, Pallocci M, Passalacqua P, Di Giampaolo L, Coppeta L. Questionable Immunity to Mumps among Healthcare Workers in Italy—A Cross-Sectional Serological Study. Vaccines. 2024; 12(5):522. https://doi.org/10.3390/vaccines12050522
Chicago/Turabian StyleFerrari, Cristiana, Giuseppina Somma, Michele Treglia, Margherita Pallocci, Pierluigi Passalacqua, Luca Di Giampaolo, and Luca Coppeta. 2024. "Questionable Immunity to Mumps among Healthcare Workers in Italy—A Cross-Sectional Serological Study" Vaccines 12, no. 5: 522. https://doi.org/10.3390/vaccines12050522